Your trusted small molecule CDMO partner
Through a comprehensive small molecule service offering, we support our customers’ molecules throughout their entire journey to market, from early-stage development through to commercial-scale manufacture. ... Read more
For more than 50 years, we have delivered comprehensive API development and small molecule manufacturing solutions to leading pharmaceutical and biotechnology organisations, empowering our customers to overcome their most complex scientific challenges and maximise value.
In addition to offering the comprehensive services needed to bring a molecule to market, as your small molecule development and manufacturing partner, we offer unparalleled support and a highly differentiated customer experience to make your life easier along the way.
Our unwavering commitment to providing our customers a simple and collaborative way of working is core to all of our services at Sterling.
We are more than a CDMO specialising in small molecule development and manufacturing, we are a PDMO®, or partnership development and manufacturing organisation.
This means that we always put your product first, and we prioritise collaboration, efficiency, quality, cost-effectiveness, and full transparency.
Small molecule services at Sterling
From our global facilities, we offer a range of small molecule services to support your programme as it scales from preclinical to commercialisation. ... Read more
Our small molecule development capabilities
As your small molecule outsourcing partner, we provide a range of API development services. From proof of concept to process optimisation, our customers benefit from direct access to our experts across the globe. Our range of services include solid state chemistry, quality by design (QbD), and CMC support to provide the data required for your new drug application (NDA) filings.
Click to see our full range of API development services.
Our small molecule manufacturing capabilities
Sterling’s API manufacturing facilities in the UK, EU and US can take your small molecule manufacturing programme from grammes to tonnes, supporting your API demands throughout the preclinical, clinical and commercial phases.
We use our small molecule manufacturing and engineering expertise to help you optimise your processes along the way, applying our knowledge within specialised areas such as hazardous chemistry, high potency APIs, micronisation and flow chemistry to yield the greatest results for your programmes.
Click to find out more about our API manufacturing services. Read less
Explore our small molecule services below
Small molecule technologies at Sterling
At Sterling, we empower our customers to remain at the forefront of pharmaceutical technology through our specialised expertise, culture of innovation, and industry-leading partnerships.
...
Read more
We harness technologies that complement our existing capabilities, such as biocatalysis and flow chemistry, while maximising value for our customers and the industry to create scalable small molecule API solutions. We have over 50 years’ experience in hazardous chemistry, and possess the knowledge, dedicated equipment and purpose-built facilities to handle a wide range of chemistries and controlled substances throughout a product’s lifecycle. Hazard evaluation is fundamental to our new product introduction (NPI) process, enabling us to identify potential hazards as a project scales from grammes to tonnes. As new technologies continue to emerge, we are continuously exploring and evaluating them for customer utility and value. Working in collaboration with our university and industry partners, we provide our customers direct access to specialised expertise as they embrace key technological breakthroughs, coupled with the state-of-the-art facilities and equipment needed to apply innovative technologies as part of a larger programme. Click to learn more about our Technology and Innovation Programme. Read less
